What Are GLP-1 Medications? Everything You Need to Know

If you've scrolled through social media lately, chances are you've seen someone talking about Ozempic. Maybe a celebrity. Maybe a coworker. Maybe your doctor brought it up at your last visit. GLP-1 medications have exploded into the mainstream over the past few years, and for good reason — they're showing results that previous weight-loss drugs never came close to matching. But there's also a lot of noise, confusion, and misinformation floating around. So let's cut through it.

What Exactly Is GLP-1?

GLP-1 stands for glucagon-like peptide-1, and it's a hormone your body already makes. Every time you eat, your gut releases GLP-1 into your bloodstream. It does a few important things: it tells your pancreas to release insulin (which lowers blood sugar), it tells your liver to chill out on producing glucose, and — here's the part everyone cares about — it signals to your brain that you're full.¹ The problem is that natural GLP-1 breaks down pretty quickly. It only lasts a few minutes in your body before enzymes called DPP-4 chop it up. So scientists figured: what if we made a version that sticks around longer? That's exactly what GLP-1 receptor agonists are — synthetic versions of GLP-1 that last days instead of minutes. They bind to the same receptors your natural GLP-1 uses, but they're built to resist breakdown. The result is a sustained signal that keeps working long after your body's own GLP-1 would have fizzled out.

How Do They Actually Work?

The mechanism is more interesting than most people realize. GLP-1 medications don't just do one thing — they hit multiple systems at once, which is part of why they're so effective. Your pancreas. When your blood sugar rises after a meal, GLP-1 agonists amplify your pancreas's insulin response. Importantly, this only happens when blood sugar is elevated — they don't cause dangerous drops in blood sugar the way some older diabetes medications can.² Your stomach. These drugs slow down how fast food leaves your stomach. Instead of a meal passing through in an hour or two, it might take four or five hours. That's why you feel full longer and eat less at your next meal. It's also why nausea is so common early on — your stomach isn't used to holding food that long. Your brain. This is arguably the most important effect. GLP-1 receptors are concentrated in the hypothalamus — the brain region that controls hunger and satiety. When these receptors are activated, your cravings quiet down. People describe it as food noise going away. You think about your next meal less. You're satisfied with smaller portions. For many people, this is the most dramatic change they experience.³ Your heart and blood vessels. Emerging research suggests GLP-1 medications have cardiovascular benefits beyond what you'd expect from weight loss alone. The SELECT trial showed semaglutide reduced major cardiovascular events by 20% in people with obesity — even those without diabetes.⁴

The Medications Available Today

Here's what's currently on the market: Semaglutide is probably the name you've heard most. It comes as Ozempic (for type 2 diabetes) and Wegovy (for weight loss). It's a weekly injection that's shown average weight loss of about 15% of body weight in clinical trials. There's also an oral version called Rybelsus, though the injectable form tends to be more effective for weight loss. Tirzepatide is the newer kid on the block, sold as Mounjaro (diabetes) and Zepbound (weight loss). What makes tirzepatide different is that it's a dual agonist — it hits both GLP-1 receptors and GIP receptors (another gut hormone). The results have been even more impressive: up to 22.5% weight loss in some trials, which is approaching what you'd see with bariatric surgery.⁵ Liraglutide (Victoza, Saxenda) was one of the first GLP-1 drugs and is still widely used. It requires daily injections rather than weekly, which is less convenient, but it's well-studied and effective. Dulaglutide (Trulicity) is another weekly option primarily used for diabetes management. It tends to cause fewer GI side effects than semaglutide, though weight loss is more modest.

Who Should Consider GLP-1 Therapy?

These medications aren't for everyone, and they're not meant to be casual weight-loss tools. They're typically recommended if you:

• Have type 2 diabetes and your current medications aren't controlling your blood sugar well enough
• Have a BMI of 30 or higher (classified as obesity)
• Have a BMI of 27 or higher with at least one weight-related health condition like high blood pressure, sleep apnea, or high cholesterol
• Have cardiovascular risk factors that could benefit from the protective effects They're not recommended as first-line treatment for people who just want to lose 10 pounds for cosmetic reasons. These are serious medications with real side effects, and they're meant to be part of a broader health strategy that includes diet, exercise, and ongoing medical supervision.

What to Actually Expect

Let's talk about what the experience is really like, because clinical trial data doesn't always capture the day-to-day reality. The first month is rough for a lot of people. You start at a low dose specifically because the GI side effects — nausea, occasional vomiting, some diarrhea — can be intense when you first begin. Most people find that their body adjusts within 2-4 weeks, but that initial period can be discouraging. The weight loss isn't instant. You might not see meaningful results until you've been on a therapeutic dose for 4-8 weeks. The studies show a gradual curve: modest loss in the first couple of months, then accelerating as you reach full dose. Patience matters here. The "food noise" disappearing is real. This is probably the most commonly reported subjective experience, and it's hard to overstate how significant it is for people who've spent their entire lives feeling controlled by cravings. Multiple studies have confirmed that GLP-1 agonists reduce activity in brain regions associated with food reward.⁶ You'll probably need to eat differently. Not because of rules, but because your body won't tolerate the same portions or types of food. Greasy, heavy meals tend to cause more nausea. Many people naturally gravitate toward smaller, lighter meals. Protein intake becomes important because you're eating less overall, and you need to preserve muscle mass. It's not a forever-or-nothing decision. There's ongoing debate about whether people can stop GLP-1 medications after reaching their goal weight. Some maintain their results; others regain. The honest answer is that we don't have great long-term data on this yet, and it likely varies by individual.

The Cost Question

Let's address the elephant in the room: these medications are expensive. Without insurance, brand-name GLP-1 drugs can cost $800-$1,300 per month. Insurance coverage varies wildly — some plans cover them generously, others don't cover weight-loss medications at all. Compounding pharmacies have emerged as a more affordable alternative, offering semaglutide and tirzepatide at significantly lower costs. However, the quality and safety of compounded versions varies, and the FDA has raised concerns about some suppliers.⁷ If you go this route, work with a provider who sources from reputable compounding pharmacies with proper oversight. Patient assistance programs from manufacturers can also help. Novo Nordisk (maker of Ozempic/Wegovy) and Eli Lilly (maker of Mounjaro/Zepbound) both offer savings programs for eligible patients.

The Bottom Line

GLP-1 medications represent a genuine breakthrough in treating obesity and type 2 diabetes. They work through multiple mechanisms, the results are impressive by any historical standard, and the safety profile — while not without concerns — is generally favorable for most patients. But they're not magic. They work best as part of a comprehensive approach: good nutrition, regular physical activity, behavioral support, and ongoing medical supervision. They're a tool, not a solution on their own. If you're considering GLP-1 therapy, talk to your doctor. Be honest about your health history, your goals, and your concerns. And be patient with the process — the results are worth the adjustment period.

References

1. Drucker, D.J. (2018). Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metabolism, 27(4), 740-756. PubMed: 29514068
2. Nauck, M.A. & Meier, J.J. (2018). Incretin hormones: Their role in health and disease. Diabetes, Obesity and Metabolism, 20(S1), 5-21. PubMed: 29364481
3. van Bloemendaal, L., et al. (2015). GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans. Diabetes, 63(12), 4186-4196. PubMed: 25008181
4. Lincoff, A.M., et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine, 389(24), 2221-2232. PubMed: 37952141
5. Jastreboff, A.M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 387(3), 205-216. PubMed: 35658024
6. Ten Kulve, J.S., et al. (2016). GLP-1 affects hypothalamic regulation of appetite. Diabetes, 65(6), 1716-1723. PubMed: 26993055
7. FDA (2024). Compounded GLP-1 Products: FDA Concerns. FDA.gov